Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis
Michael W. Konstan(Roche (Switzerland)), Charles A. Johnson(Atara Biotherapeutics (United States)), Marcia Craib(Atara Biotherapeutics (United States)), Stefanie J. Silva(Ovation Fertility), Warren E. Regelmann(University of Minnesota), Wayne J. Morgan(University of Arizona), Jeffrey S. Wagener(Children's Hospital Colorado), Mary Ellen B. Wohl(Roche (Switzerland)), David J. Pasta(Ovation Fertility), Steven M. Butler(Einstein Medical Center Philadelphia), Dennis C. Stokes(Children's Hospital at Dartmouth Hitchcock)
Cited by 441
Related Papers
Asthma and Wheezing in the First Six Years of Life
|New England Journal of Medicine|1995|3.8k
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
|The Lancet|1999|1.6k
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma
|New England Journal of Medicine|2006|1.1k
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
|New England Journal of Medicine|2004|1.1k